S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial
Yamada, Y., Denda, T., Gamoh, M., Iwanaga, I., Yuki, S., Shimodaira, H., Nakamura, M., Yamaguchi, T., Ohori, H., Kobayashi, K., Tsuda, M., Kobayashi, Y., Miyamoto, Y., Kotake, M., Shimada, K., Sato, A., Morita, S., Takahashi, S., Komatsu, Y., Ishioka, C.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC)
Sunakawa, Y., Nakamura, M., Ishizaki, M., Kataoka, M., Satake, H., Kitazono, M., Yanagisawa, H., Kawamoto, Y., Kuramochi, H., Ohori, H., Nakamura, M., Takahashi, K., Maeda, F., Komeno, C., Takeuchi, M., Fujii, M., Yoshino, T., Ichikawa, W., Tsuji, A.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
A feasibility study of edoxaban for the cancer-associated asymptomatic venous thromboembolism in Japanese gastrointestinal cancer patients receiving chemotherapy (ExCAVE study)
Nakamura, M., Yagisawa, M., Saiki, T., Ishiguro, A., Sawada, K., Yuki, S., Sasaki, T., Ando, T., Ohori, H., Kotaka, M., Muto, O., Shindo, Y., Nakashima, K., Hosokawa, A., Doi, A., Izawa, N., Sunakawa, Y., Satoh, A., Ono, K., Komatsu, Y.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Updated analysis and exploratory analysis of primary tumor location in the TRICOLORE trial: A randomized phase III trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer
Nakamura, M, Takashima, A, Denda, T, Gamoh, M, Iwanaga, I, Komatsu, Y, Takahashi, M, Ohori, H, Sekikawa, T, Tsuda, M, Kobayashi, Y, Miyamoto, Y, Kotake, M, Ishioka, C, Shimada, K, Sato, A, Yuki, S, Morita, S, Takahashi, S, Yamaguchi, T
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
38P Modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab for right-sided or BRAF mutant metastatic colorectal cancer (mCRC): Subgroup analysis of the DEEPER trial (JACCRO CC-13)
Sunakawa, Y., Shiozawa, M., Kawai, T., Ota, H., Yasui, H., Kochi, M., Manaka, D., Ohori, H., Matsuura, M., Shinohara, Y., Takeuchi, M., Ichikawa, W., Fujii, M., Tsuji, A.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
90MO Panitumumab (PAN) vs bevacizumab (BEV) in metastatic colorectal cancer (mCRC) by microsatellite stable (MSS), RAS/BRAF, and HER2 amplification (HER2amp) status: Phase III PARADIGM biomarker study
Kato, T., Muro, K., Watanabe, J., Shitara, K., Yamazaki, K., Ohori, H., Shiozawa, M., Yasui, H., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Soeda, J., Yamamoto, K., Yamashita, R., Akagi, K., Ochiai, A., Uetake, H., Tsuchihara, K., Yoshino, T.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
555MO Modified (m)-FOLFOXIRI plus cetuximab treatment and predictive clinical factors for RAS/BRAF wild-type and left-sided metastatic colorectal cancer (mCRC): The DEEPER trial (JACCRO CC-13)
Sunakawa, Y., Shiozawa, M., Watanabe, T., Ota, H., Yasui, H., Kochi, M., Manaka, D., Ohori, H., Yamaguchi, T., Matsuura, M., Shinohara, Y., Miyake, T., Sagawa, T., Tanaka, C., Okamura, S., Takeuchi, M., Ichikawa, W., Fujii, M., Tsuji, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
388P Early tumor shrinkage (ETS) and depth of response (DpR) analyses in metastatic colorectal cancer (mCRC) treated with first-line mFOLFOX6 plus panitumumab (PAN) or bevacizumab (BEV): Results from the phase III PARADIGM trial
Muro, K., Watanabe, J., Shitara, K., Yamazaki, K., Ohori, H., Shiozawa, M., Yasui, H., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Kato, T., Hihara, M., Soeda, J., Yamamoto, K., Akagi, K., Ochiai, A., Uetake, H., Tsuchihara, K., Yoshino, T.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
LBA O-10 First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results
Muro, K., Watanabe, J., Shitara, K., Yamazaki, K., Ohori, H., Shiozawa, M., Yasui, H., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Kato, T., Hihara, M., Soeda, J., Yamamoto, K., Akagi, K., Ochiai, A., Uetake, H., Yoshino, T.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
SO-25 Modified (m)-FOLFOXIRI plus cetuximab versus m-FOLFOXIRI plus bevacizumab as initial treatment for RAS and BRAF wild-type metastatic colorectal cancer: Updated survival analysis of the DEEPER trial by JACCRO
Sunakawa, Y., Shiozawa, M., Watanabe, T., Ota, H., Yasui, H., Kochi, M., Manaka, D., Ohori, H., Yamaguchi, T., Kyogoku, T., Sagawa, T., Kubota, Y., Masuishi, T., Kotaka, M., Sekikawa, T., Shimada, K., Nakamura, M., Takeuchi, M., Ichikawa, W., Fujii, M., Tsuji, A.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
PD-013RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC)
Sunakawa, Y, Nakamura, M, Nakamura, M, Ishizaki, M, Kataoka, M, Satake, H, Kitazono, M, Yanagisawa, H, Kawamoto, Y, Kuramochi, H, Ohori, H, Takahashi, K, Maeda, F, Komeno, C, Takeuchi, M, Fujii, M, Yoshino, T, Ichikawa, W, Tsuji, A
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
452TiPA feasibility study of edoxaban for the cancer-associated asymptomatic venous thromboembolism in Japanese gastrointestinal cancer patients receiving chemotherapy (ExCAVE study)
Nakamura, M, Yagisawa, M, Saiki, T, Ishiguro, A, Sawada, K, Yuki, S, Sasaki, T, Ando, T, Ohori, H, Kotaka, M, Muto, O, Shindo, Y, Nakashima, K, Hosokawa, A, Doi, A, Izawa, N, Sunakawa, Y, Satoh, A, Ono, K, Komatsu, Y
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
475PUpdated analysis and exploratory analysis of primary tumor location in the TRICOLORE trial: A randomized phase III trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer
Nakamura, M, Takashima, A, Denda, T, Gamoh, M, Iwanaga, I, Komatsu, Y, Takahashi, M, Ohori, H, Sekikawa, T, Tsuda, M, Kobayashi, Y, Miyamoto, Y, Kotake, M, Ishioka, C, Shimada, K, Sato, A, Yuki, S, Morita, S, Takahashi, S, Yamaguchi, T
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article